isoniazid + prednisolone

Isoniazid + prednisolone is a combination of two small molecule drugs, each with distinct mechanisms and indications. Isoniazid is an antibiotic primarily used for the treatment and prevention of tuberculosis by inhibiting the synthesis of mycolic acids, essential components of the mycobacterial cell wall. Prednisolone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties, acting mainly through binding to the glucocorticoid receptor to inhibit pro-inflammatory signals and promote anti-inflammatory effects. This combination does not represent a standard fixed-dose product but may be co-administered in certain clinical scenarios where both antimicrobial therapy (e.g., for tuberculosis) and immunosuppression or inflammation control are required. Notably, pharmacokinetic interactions exist between these agents; prednisolone can decrease plasma concentrations of isoniazid by enhancing its renal clearance and increasing its acetylation rate in slow acetylators[2][4][3]. The use of this combination should be carefully monitored due to potential drug-drug interactions.